OCT 22 2003
510(k) SUMMARY

Submitter: Cynsoure, Inc.

10 Elizabeth Drive
Chelmsford, MA 01824

Contact: George Cho
Senior Vice President of Medical Technology

Date Summary Prepared: August 19, 2003

Device Trade Name: PhotoGenica VL

Common Name: Medical Laser System

Classification Name: Instrument, surgical, powered, laser
79-GEX
21 CFR 878.4810

Equivalent Device: Nlite Laser by ICN, and Cynosure PhotoGenica VL

Device Description: The PhotoGenica VL is a pulse-dye laser, having the
organic dye as the lasing medium. It is a pulsed laser
with a wavelength of 580 to 590nm.

Laser activation is both by finger switch and footswitch.
Overall weight of the laser is 285lbs, and the size is
44”x19"x24” (HxWxD).

Electrical requirement is 110 VAC or 220 VAC, 20A,
50-60 Hz, single phase.

Intended Use: The PhotoGenica VL is indicated for treatment of
periocular wrinkles, vascular lesions and inflammatory
acne.

Comparison: The PhotoGenica VL laser has an equivalent indication
for uses, the same principle of operation, the same
wavelength and pulse energy range as the predicate
devices.

Nonclinical Performance Data: none

Clinical Performance Data: none

Conclusion: The PhotoGenica VL Laser is another safe and effective
device for dermatologic applications.

Additional Information: none

i pretty
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
EeE>E————_—_—~—_OEOe
Pe Food and Drug Administration
9200 Corporate Boulevard
OCT 2 2 2003 Rockville MD 20850
Mr. George Cho
Senior Vice President of Medical Technology
Cynosure, Inc.
10 Elizabeth Drive : :
Chelmsford, Massachusetts 01824
Re: K032565
Trade/Device Name: PhotoGenica VL
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and .
plastic surgery and in dermatology
Regulatory Class: II :
Product Code: GEX .
Dated: August 19, 2003
Received: August 21, 2003
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general contrels provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. George Cho
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled.
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.tda.gow/cdrh/dsma/dsmamain.hun| :

Sincerely yours, .

f Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure ‘ .

t
, 2
501(k) Number (if known): 0 DAE
Device Name: Cynosure PhotoGenica VL
Indications For Use:
The Cynosure PhotoGenica VL laser is indicated for use in Dermatological and
Plastic Surgery applications and the treatment of periocular wrinkles, vascular .
lesions and inflammatory acne vulgaris.
PLEASE DO NOT WRITE BELOW THIS LINE — CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
f (Division Sign-Off)
Division of General, Restorative
and Neurological Devices
. KO
. 19(k) Number___" “7. S$ asé S
Prescription Use / OR Over-the-Counter Use
(Per 21 CFR 801.109)
(Optional Format | -2-96)

